Should I buy or sell Inotiv stock right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Inotiv in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" NOTV shares. View NOTV analyst ratings or view top-rated stocks .

What is Inotiv's stock price target for 2024?

3 equities research analysts have issued 1 year price objectives for Inotiv's stock. Their NOTV share price targets range from $9.00 to $25.00. On average, they predict the company's share price to reach $15.17 in the next twelve months. This suggests a possible upside of 251.1% from the stock's current price. View analysts price targets for NOTV or view top-rated stocks among Wall Street analysts .

How have NOTV shares performed in 2024?

Inotiv's stock was trading at $3.67 at the beginning of 2024. Since then, NOTV shares have increased by 17.7% and is now trading at $4.32. View the best growth stocks for 2024 here .

When is Inotiv's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 9th 2024. View our NOTV earnings forecast .

How were Inotiv's earnings last quarter?

Inotiv, Inc. (NASDAQ:NOTV) announced its quarterly earnings data on Wednesday, February, 7th. The company reported ($0.60) earnings per share for the quarter, missing the consensus estimate of $0.07 by $0.67. The business earned $135.50 million during the quarter, compared to analysts' expectations of $136.26 million. Inotiv had a negative trailing twelve-month return on equity of 10.99% and a negative net margin of 5.67%.

What guidance has Inotiv issued on next quarter's earnings?

Inotiv issued an update on its FY 2024 earnings guidance on Wednesday, February, 7th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $580.0 million-$590.0 million, compared to the consensus revenue estimate of $578.1 million.

Who are Inotiv's major shareholders?

Inotiv's stock is owned by a variety of institutional and retail investors. Top institutional investors include Denali Advisors LLC (0.10%). Insiders that own company stock include Gregory Cole Davis, James Harkness, John E Sagartz, John E Sagartz , John Gregory Beattie, Michael Garrett, Philip A Downing , R Matthew Neff, Robert Jr Leasure and William D Pitchford. View institutional ownership trends .

How do I buy shares of Inotiv?

Shares of NOTV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:NOTV

Inotiv (NOTV) Stock Price, News & Analysis

→ The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad)

Free NOTV Stock Alerts

$4.32

-0.38 (-8.09%)

(As of 04/19/2024 ET)

Compare

Today's Range: $4.28
▼
$4.81
50-Day Range: $4.32
▼
$11.04
52-Week Range: $1.61
▼
$11.42

Volume: 702,739 shs
Average Volume: 492,164 shs
Market Capitalization: $111.41 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $15.17

Get Inotiv alerts:

Inotiv MarketRank™ Stock Analysis

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 251.1% Upside
$15.17 Price Target
Short Interest: Healthy
4.07% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 0.00
Based on 2 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: 23.08%
From $1.04 to $1.28 Per Share

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.85 out of 5 stars

Medical Sector

393rd out of 911 stocks

Commercial Physical Research Industry

6th out of 12 stocks

3.5

Analyst's Opinion

Consensus Rating
Inotiv has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.
Amount of Analyst Coverage
Inotiv has only been the subject of 1 research reports in the past 90 days.

5.0

Short Interest

Percentage of Shares Shorted
4.07% of the float of Inotiv has been sold short.
Short Interest Ratio / Days to Cover
Inotiv has a short interest ratio ("days to cover") of 2.3, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Inotiv has recently decreased by 12.47%, indicating that investor sentiment is improving significantly.

0.0

Dividend Strength

Dividend Yield
Inotiv does not currently pay a dividend.
Dividend Growth
Inotiv does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for NOTV.

0.0

News and Social Media Coverage

News Coverage This Week
MarketBeat has tracked 2 news articles for Inotiv this week, compared to 1 article on an average week.
Search Interest
Only 15 people have searched for NOTV on MarketBeat in the last 30 days. This is a decrease of -25% compared to the previous 30 days.
MarketBeat Follows
Only 3 people have added Inotiv to their MarketBeat watchlist in the last 30 days. This is a decrease of -40% compared to the previous 30 days.

0.0

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Inotiv insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 5.80% of the stock of Inotiv is held by insiders.
Percentage Held by Institutions
Only 18.17% of the stock of Inotiv is held by institutions.

2.5

Earnings and Valuation

Earnings Growth
Earnings for Inotiv are expected to grow by 23.08% in the coming year, from $1.04 to $1.28 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Inotiv is -3.32, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Inotiv is -3.32, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Inotiv has a P/B Ratio of 0.41. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad DTI

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

About Inotiv Stock (NASDAQ:NOTV)

Inotiv, Inc. provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries. It operates through two segment: Discovery and Safety Assessment (DSA), and Research Models and Services (RMS). The DMS segment manufactured scientific instruments for life sciences research and the related software for use by pharmaceutical companies, universities, government research centers, and medical research institutions under the Company's BASi product line. The RMS segment engages in commercial production and sales of research models, diets, bedding, and bioproducts. The company offers research and discovery services, including computational toxicology, disease pharmacology, DMPK, safety pharmacology, discovery bioanalysis, exploratory, surgical models and medical device, and cell and molecular biology; non-clinical safety assessment includes general and genetic toxicology, regulated bioanalysis, carcinogenicity studies, and development and reproductive toxicology; pathology services, such as histology, digital, clinical, and medical device pathology; bioanalysis includes nonregulated discovery bioanalysis, biotherapeutics, and regulated preclinical and clinical bioanalysis; proteomics; and consulting services, as well as model and research services. The company operates in the United States, the Netherlands, and internationally. The company was formerly known as Bioanalytical Systems, Inc. and changed its name to Inotiv, Inc. in March 2021. Inotiv, Inc. was incorporated in 1974 and is headquartered in West Lafayette, Indiana.

NOTV Stock Price History

30 days | 90 days | 365 days | Advanced Chart

NOTV Stock News Headlines

April 19, 2024 | prnewswire.com

INOTIV INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Inotiv, Inc. - NOTV

April 16, 2024 | finance.yahoo.com

Inotiv, Inc. (NOTV) Interactive Stock Chart - Yahoo Finance

April 20, 2024 | DTI (Ad)

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

April 8, 2024 | markets.businessinsider.com

Analysts Offer Insights on Healthcare Companies: Natera (NTRA) and Inotiv (NOTV)

April 5, 2024 | businesswire.com

INOTIV INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Inotiv, Inc. - NOTV

April 5, 2024 | seekingalpha.com

Inotiv Stock: Financial Turnaround Overshadowed By Animal Testing Controversies

March 26, 2024 | markets.businessinsider.com

Craig-Hallum Keeps Their Buy Rating on Inotiv (NOTV)

March 20, 2024 | finance.yahoo.com

NOTV May 2024 10.000 call

April 20, 2024 | DTI (Ad)

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

March 20, 2024 | finance.yahoo.com

NOTV Apr 2024 17.500 call

March 13, 2024 | finance.yahoo.com

NOTV Apr 2024 2.500 call

March 12, 2024 | investorplace.com

Rocket Stocks: 3 Picks That Could Skyrocket Your Portfolio by 2025

February 29, 2024 | finance.yahoo.com

Here's What Could Help Inotiv, Inc. (NOTV) Maintain Its Recent Price Strength

February 28, 2024 | morningstar.com

Inotiv Inc NOTV

February 27, 2024 | investorplace.com

3 Overlooked Stocks with Potential for 500% Growth by 2025

February 24, 2024 | msn.com

Inotiv (NOTV) Price Target Increased by 10.71% to 15.81

February 23, 2024 | benzinga.com

Inotiv Stock (NASDAQ:NOTV) Insider Trades

February 23, 2024 | benzinga.com

Inotiv Stock (NASDAQ:NOTV) Earnings Dates and Earning Calls

February 20, 2024 | investorplace.com

Millionaire-Makers: 3 Game-Changing Stocks Ready for Historic Gains

February 19, 2024 | finance.yahoo.com

Inotiv, Inc. (NOTV) Is Attractively Priced Despite Fast-paced Momentum

February 14, 2024 | finance.yahoo.com

Are Investors Undervaluing Inotiv (NOTV) Right Now?

February 11, 2024 | finance.yahoo.com

Earnings Update: Here's Why Analysts Just Lifted Their Inotiv, Inc. (NASDAQ:NOTV) Price Target To US$15.50

February 9, 2024 | msn.com

Jefferies upgrades Inotiv to buy, cites expanded sales force

February 9, 2024 | markets.businessinsider.com

CyberArk Software To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Friday

February 9, 2024 | finance.yahoo.com

Inotiv First Quarter 2024 Earnings: Beats Expectations

February 9, 2024 | finance.yahoo.com

Inotiv, Inc. (NASDAQ:NOTV) Q1 2024 Earnings Call Transcript

February 9, 2024 | finanznachrichten.de

Inotiv, Inc.: Inotiv Reports First Quarter Financial Results for Fiscal 2024 and Provides Business Update

See More Headlines

Receive NOTV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Inotiv and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 2/07/2024
Today: 4/20/2024
Next Earnings (Estimated): 5/09/2024
Fiscal Year End: 9/30/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Commercial physical research
Sub-Industry: N/A
Current Symbol: NASDAQ:NOTV
CUSIP: N/A
CIK: 720154
Web: www.inotivco.com
Phone: (765) 463-4527
Fax: 765-497-1102
Employees: 2,055
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $15.17
High Stock Price Target: $25.00
Low Stock Price Target: $9.00
Potential Upside/Downside: +251.1%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 3 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($1.30)
Trailing P/E Ratio: N/A
Forward P/E Ratio: 4.15
P/E Growth: N/A
Net Income: $-105,140,000.00
Net Margins: -5.67%
Pretax Margin: -6.95%
Return on Equity: -10.99%
Return on Assets: -3.45%

Debt

Debt-to-Equity Ratio: 1.46
Current Ratio: 1.74
Quick Ratio: 1.28

Sales & Book Value

Annual Sales: $572.42 million
Price / Sales: 0.19
Cash Flow: $0.34 per share
Price / Cash Flow: 12.55
Book Value: $10.41 per share
Price / Book: 0.41

Miscellaneous

Outstanding Shares: 25,790,000
Free Float: 24,295,000
Market Cap: $111.41 million
Optionable: Optionable
Beta: 3.16

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

Key Executives

Mr. Robert W. Leasure Jr. (Age 64)
President, CEO & Director
Comp: $2M
Ms. Beth A. Taylor CPA (Age 59)
Senior VP of Finance & CFO
Comp: $461.16k
Dr. John E. Sagartz D.V.M. (Age 58)
DiplomateACVP, Ph.D., Chief Strategy Officer & Director
Comp: $438.61k
Dr. Peter T. Kissinger (Age 79)
Founder, Chairman Emeritus & Scientific Advisor
Comp: $330.12k
Mr. Brennan Freeman (Age 37)
VP of Finance, Principal Accounting Officer & Corporate Controller
Ms. Andrea Castetter
Senior VP, General Counsel & Corporate Secretary
Dr. Adrian Hardy Ph.D. (Age 53)
Executive VP of Global Marketing & Corporate Development
Comp: $2.74M
Mr. Jeffrey Arthur Krupp (Age 53)
Chief Human Resources Officer
Mr. John Gregory Beattie DSA (Age 57)
Chief Operating Officer of DSA
Mr. Michael Garrett M.S. (Age 56)
Chief Commercial Officer

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

NOTV Stock Analysis - Frequently Asked Questions

Should I buy or sell Inotiv stock right now?: 3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Inotiv in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" NOTV shares.
View NOTV analyst ratings or view top-rated stocks.
What is Inotiv's stock price target for 2024?: 3 equities research analysts have issued 1 year price objectives for Inotiv's stock. Their NOTV share price targets range from $9.00 to $25.00. On average, they predict the company's share price to reach $15.17 in the next twelve months. This suggests a possible upside of 251.1% from the stock's current price.
View analysts price targets for NOTV or view top-rated stocks among Wall Street analysts.
How have NOTV shares performed in 2024?: Inotiv's stock was trading at $3.67 at the beginning of 2024. Since then, NOTV shares have increased by 17.7% and is now trading at $4.32.
View the best growth stocks for 2024 here.
When is Inotiv's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, May 9th 2024.
View our NOTV earnings forecast.

How were Inotiv's earnings last quarter?: Inotiv, Inc. (NASDAQ:NOTV) announced its quarterly earnings data on Wednesday, February, 7th. The company reported ($0.60) earnings per share for the quarter, missing the consensus estimate of $0.07 by $0.67. The business earned $135.50 million during the quarter, compared to analysts' expectations of $136.26 million. Inotiv had a negative trailing twelve-month return on equity of 10.99% and a negative net margin of 5.67%.
What guidance has Inotiv issued on next quarter's earnings?: Inotiv issued an update on its FY 2024 earnings guidance on Wednesday, February, 7th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $580.0 million-$590.0 million, compared to the consensus revenue estimate of $578.1 million.
Who are Inotiv's major shareholders?: Inotiv's stock is owned by a variety of institutional and retail investors. Top institutional investors include Denali Advisors LLC (0.10%). Insiders that own company stock include Gregory Cole Davis, James Harkness, John E Sagartz, John E Sagartz, John Gregory Beattie, Michael Garrett, Philip A Downing, R Matthew Neff, Robert Jr Leasure and William D Pitchford.
View institutional ownership trends.
How do I buy shares of Inotiv?: Shares of NOTV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:NOTV) was last updated on 4/20/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Inotiv (NOTV) Stock Price, News & Analysis

Inotiv MarketRank™ Stock Analysis

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

News Coverage This Week

Search Interest

MarketBeat Follows

Company Ownership

Earnings and Valuation

About Inotiv Stock (NASDAQ:NOTV)

NOTV Stock Price History

NOTV Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Insiders & Institutions

NOTV Stock Analysis - Frequently Asked Questions

Overall MarketRank^™